Related Experiment Videos
[Trophoblastic beta-globulin in immunoglobulin preparations]
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|January 1, 1983
Summary
Commercial immunoglobulin preparations often contain trophoblastic beta-globulin, particularly those derived from placental blood serum. Detecting this protein admixture is crucial for assessing the quality and purification of immunoglobulin products.
Area of Science:
- Biochemistry
- Immunology
- Pharmaceutical Science
Context:
- Investigated 142 commercial immunoglobulin lots from 20 manufacturers.
- Sera sources included placental, abortion, and donor blood.
- Focused on the presence of trophoblastic beta-globulin.
Purpose:
- To quantify trophoblastic beta-globulin in commercial immunoglobulin preparations.
- To assess the prevalence of this protein in products from different blood sources.
- To evaluate the utility of trophoblastic beta-globulin detection for quality control.
Summary:
- Trophoblastic beta-globulin was detected in 83% of abortion blood serum lots and 94% of placental blood serum lots.
- Concentration was significantly higher in placental blood serum-derived immunoglobulin.
- A detection method for this beta-globulin can indicate purification effectiveness.
Impact:
- Highlights potential quality control issues in commercial immunoglobulin production.
- Suggests a method for improving the safety and efficacy of immunoglobulin therapies.
- Informs manufacturers about the need for enhanced purification processes.